{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:49:19Z","timestamp":1792352959580,"version":"4.4.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2022-310"],"award-info":[{"award-number":["075-15-2022-310"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.heliyon.2024.e41457","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:27:53Z","timestamp":1735079273000},"page":"e41457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors"],"prefix":"10.1016","volume":"11","author":[{"given":"Ekaterina","family":"Filipovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Gorodkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Shcherbakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Melnichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Mokrysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-4188","authenticated-orcid":false,"given":"Marina","family":"Utkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e41457_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1085\/jgp.47.4.691","article-title":"Electrical properties of hypothalamic neuroendocrine cells","volume":"47","author":"Kandel","year":"1964","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib2","series-title":"Recent Advances in the Developmental Origin of Neuroblastoma: an Overview","first-page":"41","author":"Ponzoni","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e41457_bib3","doi-asserted-by":"crossref","DOI":"10.1242\/dev.202821","article-title":"A pre-vertebrate endodermal origin of calcitonin-producing neuroendocrine cells","volume":"151","author":"Rees","year":"2024","journal-title":"Development"},{"key":"10.1016\/j.heliyon.2024.e41457_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.heliyon.2024.e41457_bib5","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14737140.2017.1285230","article-title":"Overview and recent advances in the treatment of neuroblastoma","volume":"17","author":"Whittle","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.heliyon.2024.e41457_bib7","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e41457_bib8","first-page":"159","article-title":"Pheochromocytoma and paraganglioma: from epidemiology to clinical findings","volume":"54","author":"Aygun","year":"2020","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"10.1016\/j.heliyon.2024.e41457_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature03097","article-title":"Cell-cycle checkpoints and cancer","volume":"432","author":"Kastan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e41457_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ceb.2007.02.009","article-title":"DNA damage checkpoints: from initiation to recovery or adaptation","volume":"19","author":"Bartek","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.cr.7290031","article-title":"Regulation of the G1 phase of the mammalian cell cycle","volume":"10","author":"Donjerkovic","year":"2000","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib12","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/sj.onc.1208616","article-title":"DNA replication and progression through S phase","volume":"24","author":"Takeda","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e41457_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of cell cycle transcription during G1 and S phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-016-0433-9","article-title":"Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword","volume":"35","author":"Visconti","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/344503a0","article-title":"Universal control mechanism regulating onset of M-phase","volume":"344","author":"Nurse","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e41457_bib16","first-page":"3689","article-title":"The Pezcoller lecture: cancer cell cycles revisited","volume":"60","author":"Sherr","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib17","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/MCB.20.16.6147-6158.2000","article-title":"Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity","volume":"20","author":"Franklin","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e41457_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib20","article-title":"Targeting the cell cycle: a new approach to cancer therapy","author":"Schwartz","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1081\/CNV-120025095","article-title":"Bryostatin-1: a novel PKC inhibitor in clinical development","volume":"21","author":"Kortmansky","year":"2003","journal-title":"Cancer Invest."},{"key":"10.1016\/j.heliyon.2024.e41457_bib23","series-title":"Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas","year":"2014"},{"key":"10.1016\/j.heliyon.2024.e41457_bib24","author":"Roschewski"},{"key":"10.1016\/j.heliyon.2024.e41457_bib26","series-title":"A Phase I Study of Intravenous CCI-779 in Combination with Bryostatin-1 in Solid Tumors (10038414)","year":"2013"},{"key":"10.1016\/j.heliyon.2024.e41457_bib28","author":"Anderson Cancer Center"},{"key":"10.1016\/j.heliyon.2024.e41457_bib29","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/1078-0432.CCR-23-0459","article-title":"FDA Approval Summary: selpercatinib for the treatment of advanced RET fusion-positive solid tumors","volume":"29","author":"Duke","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib30","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1158\/1078-0432.CCR-12-0411","article-title":"Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary","volume":"18","author":"Thornton","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1477-7819-8-111","article-title":"Cell cyclins: triggering elements of cancer or not?","volume":"8","author":"Stamatakos","year":"2010","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib36","first-page":"261","article-title":"The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors","volume":"124","author":"Hives","year":"2023","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.heliyon.2024.e41457_bib37","first-page":"5170","article-title":"Cyclin E: a potential treatment target to reverse cancer chemoresistance by regulating the cell cycle","volume":"12","author":"Pang","year":"2020","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib38","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/ijms22062935","article-title":"Cyclin-dependent kinases (CDK) and their role in diseases development-review","volume":"22","author":"\u0141ukasik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e41457_bib39","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.3390\/molecules29225239","article-title":"Cyclin-dependent kinase inhibitors in the rare subtypes of melanoma therapy","volume":"29","author":"Kaszubski","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e41457_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.tcb.2018.07.002","article-title":"CDK4\/6 inhibition in cancer: beyond cell cycle arrest","volume":"28","author":"Goel","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2017.02.008","article-title":"Inhibitors of cyclin-dependent kinases as cancer therapeutics","volume":"173","author":"Whittaker","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e41457_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12935-022-02747-z","article-title":"A review on the role of cyclin dependent kinases in cancers","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e41457_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.2683079","article-title":"Checkpoints: controls that ensure the order of cell cycle events","volume":"246","author":"Hartwell","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e41457_bib45","first-page":"88","article-title":"A review on cell cycle checkpoints in relation to cancer","volume":"5","author":"Ray","year":"2020","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e41457_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pbc.21195","article-title":"Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma","volume":"50","author":"Woo","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","article-title":"NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer","volume":"4","author":"Fan","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.heliyon.2024.e41457_bib48","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","article-title":"NF-\u03baB and AP-1 connection: mechanism of NF-\u03baB-Dependent regulation of AP-1 activity","volume":"24","author":"Fujioka","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib49","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e41457_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107492","article-title":"Role of Rad51 and DNA repair in cancer: a molecular perspective","volume":"208","author":"Laurini","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e41457_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2016.02.003","article-title":"DNA repair targeted therapy: the past or future of cancer treatment?","volume":"160","author":"Gavande","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e41457_bib52","doi-asserted-by":"crossref","first-page":"s1107","DOI":"10.2741\/1131","article-title":"BRCA1 in cancer, cell cycle and genomic stability","volume":"8","author":"Jhanwar-Uniyal","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.heliyon.2024.e41457_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2015.00157","article-title":"DNA repair mechanisms in cancer development and therapy","volume":"6","author":"Torgovnick","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2024.e41457_bib54","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s43018-020-00139-8","article-title":"Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy","volume":"1","author":"Samstein","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib55","article-title":"Endocrine and neuroendocrine tumours [Internet]. Lyon (France): international agency for research on cancer","volume":"10","year":"2022","journal-title":"WHO Classification of Tumours Series"},{"key":"10.1016\/j.heliyon.2024.e41457_bib56","unstructured":"What is the minimum number of cells that can be profiled?, 10X Genomics (n.d.). https:\/\/kb.10xgenomics.com\/hc\/en-us\/articles\/115001800523-What-is-the-minimum-number-of-cells-that-can-be-profiled (accessed December 16, 2024)."},{"key":"10.1016\/j.heliyon.2024.e41457_bib57","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/s41467-023-38239-5","article-title":"Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma","volume":"14","author":"Thirant","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e41457_bib58","article-title":"Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma","volume":"27","author":"Van Haver","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.heliyon.2024.e41457_bib59","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.gendis.2021.12.020","article-title":"Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma","volume":"9","author":"Liu","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.heliyon.2024.e41457_bib60","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ccell.2020.08.014","article-title":"Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma","volume":"38","author":"Dong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2024.e41457_bib61","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/ncomms3478","article-title":"Gene regulation and priming by topoisomerase II\u03b1 in embryonic stem cells","volume":"4","author":"Thakurela","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e41457_bib62","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.1997.227","article-title":"The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues","volume":"75","author":"Turley","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib63","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib64","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108780","article-title":"Schwann cell precursors represent a neural crest\u2010like state with biased multipotency","volume":"41","author":"Kastriti","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41588-021-00806-1","article-title":"Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma","volume":"53","author":"Jansky","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e41457_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/excr.1994.1341","article-title":"Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A","volume":"215","author":"Prosperi","year":"1994","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","article-title":"Cyclins and cell cycle checkpoints","volume":"39","author":"Johnson","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.devcel.2014.03.012","article-title":"Cyclin B1\/Cdk1 coordinates mitochondrial respiration for cell-cycle G2\/M progression","volume":"29","author":"Wang","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.heliyon.2024.e41457_bib69","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154171","article-title":"Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint","volume":"23","author":"Liu","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib70","article-title":"Cyclin A is required at two points in the human cell cycle","volume":"11","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib71","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib72","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.91.23.10918","article-title":"Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis","volume":"91","author":"Qin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e41457_bib73","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1093\/nar\/gkr1203","article-title":"E2F7 represses a network of oscillating cell cycle genes to control S-phase progression","volume":"40","author":"Westendorp","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib74","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1093\/nar\/gky218","article-title":"An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability","volume":"46","author":"Mitxelena","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib75","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.embor.7401158","article-title":"DNA-damage response control of E2F7 and E2F8","volume":"9","author":"Panagiotis Zalmas","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib76","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s41594-023-01092-7","article-title":"Transcriptional repression upon S phase entry protects genome integrity in pluripotent cells","volume":"30","author":"G\u00f6kbuget","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib77","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","article-title":"Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas","volume":"313","author":"Seeger","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e41457_bib78","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.1997.15.3.1171","article-title":"N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Soci\u00e9t\u00e9 Francaise d'Oncologie P\u00e9diatrique","volume":"15","author":"Rubie","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib79","unstructured":"The Role of MYCN in the Failure of MYCN Amplified Neuroblastoma Cell Lines to G1 Arrest After DNA Damage: Cell Cycle: Vol 5, No 22, (n.d.). https:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/cc.5.22.3443 (accessed July 30, 2024)."},{"key":"10.1016\/j.heliyon.2024.e41457_bib80","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3892\/or_00000586","article-title":"High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity","volume":"22","author":"Peirce","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","article-title":"c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms","volume":"18","author":"Wisdom","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib82","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1101\/gad.13.5.607","article-title":"Control of cell cycle progression by c-Jun is p53 dependent","volume":"13","author":"Schreiber","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.heliyon.2024.e41457_bib83","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/0008-5472.CAN-11-0051","article-title":"HOXC9 links cell cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma","volume":"71","author":"Mao","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib84","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.119.316075","article-title":"Genomic characterization of endothelial enhancers reveals a multifunctional role for NR2F2 in regulation of arteriovenous gene expression","volume":"126","author":"Sissaoui","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib85","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1073\/pnas.94.6.2362","article-title":"Dominant-negative cyclin-selective ubiquitin carrier protein E2-C\/UbcH10 blocks cells in metaphase","volume":"94","author":"Townsley","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e41457_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021651","article-title":"EZH2 depletion blocks the proliferation of colon cancer cells","volume":"6","author":"Fussbroich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e41457_bib87","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcp.20590","article-title":"Immunohistochemical evaluation of pRb2\/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus","volume":"207","author":"Merola","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12388","article-title":"Long non-coding RNA LOC554202 modulates chrodoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression","volume":"50","author":"Ma","year":"2017","journal-title":"Cell Prolif."},{"key":"10.1016\/j.heliyon.2024.e41457_bib89","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.bpj.2017.04.018","article-title":"Direct observation of cell-cycle-dependent interactions between CTCF and chromatin","volume":"112","author":"Agarwal","year":"2017","journal-title":"Biophys. J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib90","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.1061376","article-title":"Cohesin cleavage by separase required for anaphase and cytokinesis in human cells","volume":"293","author":"Hauf","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e41457_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35055073","article-title":"Growth-factor-dependent mitogenesis requires two distinct phases of signalling","volume":"3","author":"Jones","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib92","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1128\/MCB.23.16.5803-5815.2003","article-title":"Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling","volume":"23","author":"Pennock","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib93","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1634\/stemcells.2007-0914","article-title":"Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures","volume":"26","author":"Bernardino","year":"2008","journal-title":"Stem Cell."},{"key":"10.1016\/j.heliyon.2024.e41457_bib94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e41457_bib95","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest","volume":"371","author":"Hannon","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e41457_bib96","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3727\/105221610X12718619643013","article-title":"Transcritpional effects of S100B on neuroblastoma cells: perturbation of cholesterol homeostasis and interference on the cell cycle","volume":"14","author":"Bernardini","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.heliyon.2024.e41457_bib97","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib98","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/MCB.16.5.2402","article-title":"Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts","volume":"16","author":"Herrera","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib99","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.emboj.7600463","article-title":"Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signaling","volume":"23","author":"Tsao","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib100","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1093\/nar\/gkg765","article-title":"The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase \u03b5","volume":"31","author":"Post","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib101","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1101\/gad.14.7.804","article-title":"Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression","volume":"14","author":"Takahashi","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.heliyon.2024.e41457_bib102","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1080\/15548627.2021.1896157","article-title":"The BAX-binding protein MOAP1 associates with LC3 and promotes closure of the phagophore","volume":"17","author":"Chang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.heliyon.2024.e41457_bib103","first-page":"5375","article-title":"Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I\/II, MT-III) expression in relation to clinicopathological data in ovarian cancer","volume":"33","author":"Kobierzycki","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1746-1596-7-82","article-title":"High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma","volume":"7","author":"Nodin","year":"2012","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib105","first-page":"87","article-title":"Evaluation of minichromosome maintenance-3 (MCM3) in oral squamous cell carcinoma","volume":"16","author":"Rezvani","year":"2015","journal-title":"J. Dent."},{"key":"10.1016\/j.heliyon.2024.e41457_bib106","doi-asserted-by":"crossref","first-page":"39209","DOI":"10.18632\/oncotarget.16835","article-title":"Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer","volume":"8","author":"Stewart","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e41457_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1149603","article-title":"TIMP3 promotes the maintenance of neural stem-progenitor cells in the mouse subventricular zone","volume":"17","author":"Fang","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e41457_bib108","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1083\/jcb.130.3.507","article-title":"CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis","volume":"130","author":"Liao","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib109","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12967-022-03277-y","article-title":"CENPF\/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2\/M-phase cell cycle","volume":"20","author":"Huang","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e41457_bib110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87586","article-title":"Molecular classification and tumor microenvironment characteristics in pheochromocytomas","volume":"12","author":"Qin","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2024.e41457_bib111","doi-asserted-by":"crossref","unstructured":"X. Zhang, P. Lian, M. Su, Z. Ji, J. Deng, G. Zheng, W. Wang, X. Ren, T. Jiang, P. Zhang, H. Li, Single-cell transcriptome analysis identifies a unique tumor cell type producing multiple hormones in ectopic ACTH and CRH secreting pheochromocytoma, Elife 10 (n.d.) e68436. https:\/\/doi.org\/10.7554\/eLife.68436.","DOI":"10.7554\/eLife.68436"},{"key":"10.1016\/j.heliyon.2024.e41457_bib112","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbrc.2005.12.094","article-title":"Identification of DLK1 variants in pituitary- and neuroendocrine tumors","volume":"340","author":"Altenberger","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e41457_bib113","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.neo.2020.10.005","article-title":"Niche-derived soluble DLK1 promotes glioma growth","volume":"22","author":"Grassi","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.heliyon.2024.e41457_bib114","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-022-00369-9","article-title":"Dlk1 maintains adult mice long-term HSCs by activating Notch signaling to restrict mitochondrial metabolism","volume":"12","author":"Huang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1369\/00221554211048951","article-title":"Emerging roles of DLK1 in the stem cell niche and cancer stemness","volume":"70","author":"Grassi","year":"2022","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.heliyon.2024.e41457_bib116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/10445490252810276","article-title":"Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium","volume":"21","author":"Roberts","year":"2002","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib117","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/cells11050792","article-title":"Altered RBP1 gene expression impacts epithelial cell retinoic acid, proliferation, and microenvironment","volume":"11","author":"Yu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e41457_bib118","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/sj.onc.1202520","article-title":"RBP1 induces growth arrest by repression of E2F-dependent transcription","volume":"18","author":"Lai","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e41457_bib119","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s12094-019-02042-w","article-title":"Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/Snail1\/E-cadherin axis","volume":"21","author":"Jin","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.606567","article-title":"Targeting UCHL1 induces cell cycle arrest in high-risk multiple myeloma with t(4;14)","volume":"27","author":"Kamseng","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029783","article-title":"The ubiquitin peptidase UCHL1 induces G0\/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer","volume":"7","author":"Xiang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e41457_bib122","first-page":"165","article-title":"RGS5 decreases the proliferation of human ovarian carcinoma-derived primary endothelial cells through the MAPK\/ERK signaling pathway in hypoxia","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib123","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jso.22033","article-title":"The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer","volume":"105","author":"Huang","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib124","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.191422","article-title":"RGS5 plays a significant role in renal cell carcinoma","author":"Su","year":"2020","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.heliyon.2024.e41457_bib125","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.3892\/ol.2017.6009","article-title":"Growth inhibition of human breast carcinoma cells by overexpression of regulator of G-protein signaling 4","volume":"13","author":"Park","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.heliyon.2024.e41457_bib126","article-title":"STC1 promotes cell apoptosis via NF-\u03baB phospho-P65 Ser536 in cervical cancer cells","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e41457_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110659","article-title":"Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer","volume":"502","author":"Costa","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib128","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.2147\/IJGM.S329723","article-title":"STC1 is a novel biomarker associated with immune characteristics and prognosis of bladder cancer","volume":"14","author":"Sun","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.heliyon.2024.e41457_bib129","first-page":"3055","article-title":"STC1 regulates glioblastoma migration and invasion via the TGF-\u03b2\/SMAD4 signaling pathway","volume":"20","author":"Xiong","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7150\/jca.82738","article-title":"Phosphofructokinase platelet overexpression accelerated colorectal cancer cell growth and motility","volume":"14","author":"Lu","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib131","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s13402-020-00508-6","article-title":"PFKP is highly expressed in lung cancer and regulates glucose metabolism","volume":"43","author":"Shen","year":"2020","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib132","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.21873\/anticanres.14889","article-title":"Targeting CALM2 inhibits hepatocellular carcinoma growth and metastasis by suppressing E2F5-mediated cell cycle progression","volume":"41","author":"Park","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155326","article-title":"Calmodulin 2 expression is associated with poor prognosis in breast cancer","volume":"258","author":"Yang","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.heliyon.2024.e41457_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.727306","article-title":"Calmodulin 2 facilitates angiogenesis and metastasis of gastric cancer via STAT3\/HIF-1A\/VEGF-A mediated macrophage polarization","volume":"11","author":"Mu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105531","article-title":"Knockdown of CALM2 increases the sensitivity to afatinib in HER2-amplified gastric cancer cells by regulating the Akt\/FoxO3a\/Puma axis","volume":"87","author":"Sun","year":"2023","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.heliyon.2024.e41457_bib136","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1245\/s10434-017-6083-0","article-title":"High STMN1 expression is associated with cancer progression and chemo-resistance in lung squamous cell carcinoma","volume":"24","author":"Bao","year":"2017","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib137","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1007\/s13277-015-3520-1","article-title":"Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib138","doi-asserted-by":"crossref","first-page":"86325","DOI":"10.18632\/oncotarget.21149","article-title":"ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e41457_bib139","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1535-7163.MCT-21-0331","article-title":"DIRAS3: an imprinted tumor suppressor gene that regulates RAS and PI3K-driven cancer growth, motility, autophagy, and tumor dormancy","volume":"21","author":"Bildik","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.heliyon.2024.e41457_bib140","first-page":"635","article-title":"Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest","volume":"22","author":"Lu","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib141","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/eje.0.1310221","article-title":"Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor","volume":"131","author":"Liu","year":"1994","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib142","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jemt.10336","article-title":"Deconstructing the molecular mechanisms of cell cycle control in a mouse adrenocortical cell line: roles of ACTH","volume":"61","author":"Rocha","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.heliyon.2024.e41457_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108657","article-title":"The involvement of Nek2 and Notch in the proliferation of rat adrenal cortex triggered by POMC-derived peptides","volume":"9","author":"de Mendonca","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e41457_bib144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01806354","article-title":"Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients","volume":"15","author":"Ciocca","year":"1990","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.heliyon.2024.e41457_bib145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bjc.6603918","article-title":"Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation","volume":"97","author":"Minas","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib146","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mce.2009.02.013","article-title":"Expression and subcellular localization of CRH and its receptors in human endometrial cancer","volume":"305","author":"Miceli","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib147","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12022-022-09746-w","article-title":"TOP2A expression in pheochromocytoma and abdominal paraganglioma: a marker of poor clinical outcome?","volume":"34","author":"Solhusl\u00f8kk H\u00f6se","year":"2023","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib148","article-title":"Deciphering pathological behavior of pediatric medullary thyroid cancer from single-cell perspective","volume":"11","author":"Chen","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.heliyon.2024.e41457_bib149","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s44178-024-00116-6","article-title":"Medullary thyroid cancer: single-cell transcriptome and tumor evolution","volume":"3","author":"Wang","year":"2024","journal-title":"Holist. Integ. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib150","doi-asserted-by":"crossref","first-page":"23028","DOI":"10.1074\/jbc.M101544200","article-title":"A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes","volume":"276","author":"Ko","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e41457_bib151","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbrc.2008.04.099","article-title":"AIMP1\/p43 downregulates TGF-\u03b2 signaling via stabilization of smurf2","volume":"371","author":"Lee","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e41457_bib152","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0092-8674(90)90251-9","article-title":"Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation","volume":"62","author":"Laiho","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e41457_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.752642","article-title":"GPI is a prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma","volume":"11","author":"Han","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1145753","article-title":"Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer","volume":"13","author":"Ma","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.21147\/j.issn.1000-9604.2019.05.07","article-title":"Phosphoglucose isomerase gene expression as a prognostic biomarker of gastric cancer","volume":"31","author":"Huang","year":"2019","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib156","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.clinre.2016.05.001","article-title":"Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma","volume":"40","author":"Lyu","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib157","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.2147\/CMAR.S177441","article-title":"Higher autocrine motility factor\/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer","volume":"10","author":"Ma","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib158","first-page":"2667","article-title":"Expression and secretion of neuroleukin\/phosphohexose isomerase\/maturation factor as autocrine motility factor by tumor cells","volume":"58","author":"Niinaka","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13062-023-00448-9","article-title":"The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer","volume":"19","author":"Tian","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.heliyon.2024.e41457_bib160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.28887","article-title":"Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis","volume":"65","author":"Hu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e41457_bib161","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.3390\/cancers14205097","article-title":"Upregulation of succinate Dehydrogenase (SDHA) contributes to enhanced bioenergetics of ovarian cancer cells and higher sensitivity to anti-metabolic agent shikonin","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e41457_bib162","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1083\/jcb.200104036","article-title":"E-cadherin regulates cell growth by modulating proliferation-dependent \u03b2-catenin transcriptional activity","volume":"154","author":"Stockinger","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib163","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jcb.30211","article-title":"Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression","volume":"123","author":"Gharbi","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2024.e41457_bib164","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1038\/sj.onc.1207610","article-title":"The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation","volume":"23","author":"M\u00fcnz","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e41457_bib165","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1073\/pnas.1217002110","article-title":"Activation of PI3K\/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells","volume":"110","author":"Wei","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e41457_bib166","article-title":"Prominin\u20101 controls stem cell activation by orchestrating ciliary dynamics","volume":"38","author":"Singer","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib167","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12672-024-00961-x","article-title":"MAP3K4 kinase action and dual role in cancer","volume":"15","author":"Huang","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib168","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12885-024-12446-9","article-title":"PPIH acts as a potential predictive biomarker for patients with common solid tumors","volume":"24","author":"Ye","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib169","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib170","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.exphem.2014.08.006","article-title":"Rictor\/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3","volume":"42","author":"Hua","year":"2014","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib171","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.apsb.2020.01.010","article-title":"RICTOR\/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma","volume":"10","author":"Lu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2024.e41457_bib172","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biopha.2018.07.075","article-title":"Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt\/PRAS40 in esophageal squamous cell carcinoma","volume":"106","author":"Hou","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e41457_bib173","first-page":"4317","article-title":"Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer","volume":"9","author":"Bian","year":"2017","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib174","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1083\/jcb.123.2.467","article-title":"Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts","volume":"123","author":"Eidelman","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2407-7-2","article-title":"Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers","volume":"7","author":"Blumenthal","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108561","article-title":"CEA cell adhesion molecule 5 enriches functional human hematopoietic stem cells capable of long-term multi-lineage engraftment","volume":"26","author":"Ma","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.heliyon.2024.e41457_bib177","doi-asserted-by":"crossref","first-page":"11749","DOI":"10.1074\/jbc.M114.619833","article-title":"A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis","volume":"290","author":"Bagheri-Yarmand","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e41457_bib178","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/jnci\/djh226","article-title":"Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma","volume":"96","author":"Drosten","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.heliyon.2024.e41457_bib179","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.4049\/jimmunol.149.6.1934","article-title":"The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments","volume":"149","author":"Geraghty","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib180","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/acel.12234","article-title":"A genomics approach identifies senescence-specific gene expression regulation","volume":"13","author":"Lackner","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.heliyon.2024.e41457_bib181","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1038\/s41467-019-10335-5","article-title":"Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition","volume":"10","author":"Pereira","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e41457_bib182","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cellsig.2014.11.032","article-title":"ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions","volume":"27","author":"Schlienger","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2024.e41457_bib183","doi-asserted-by":"crossref","first-page":"39834","DOI":"10.18632\/oncotarget.9405","article-title":"ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling","volume":"7","author":"Davis","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e41457_bib184","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3892\/or.2017.5388","article-title":"Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer","volume":"37","author":"Gu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000134532","article-title":"Genomic organization and mapping of the human HEP-COP gene (COPA) to 1q","volume":"76","author":"Quek","year":"1997","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.heliyon.2024.e41457_bib186","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/349248a0","article-title":"\u201cCoatomer\u201d: a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles","volume":"349","author":"Waters","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e41457_bib187","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/gutjnl-2012-304037","article-title":"A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma","volume":"63","author":"Chan","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2024.e41457_bib188","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2020.07.021","article-title":"RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis","volume":"74","author":"Song","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib191","first-page":"95","article-title":"Molecular mechanisms of etoposide","volume":"14","author":"Montecucco","year":"2015","journal-title":"EXCLI J."},{"key":"10.1016\/j.heliyon.2024.e41457_bib194","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40259-019-00337-6","article-title":"CDK4\/6 inhibitors expand the therapeutic options in breast cancer: palbociclib, ribociclib and abemaciclib","volume":"33","author":"Eggersmann","year":"2019","journal-title":"BioDrugs"},{"key":"10.1016\/j.heliyon.2024.e41457_bib195","series-title":"FDA Approves Tazemetostat for Advanced Epithelioid Sarcoma","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e41457_bib196","series-title":"FDA Granted Accelerated Approval to Tazemetostat for Follicular Lymphoma","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e41457_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112421","article-title":"A multi-scale systems pharmacology approach uncovers the anti-cancer molecular mechanism of Ixabepilone","volume":"199","author":"Cao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e41457_bib202","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1158\/1078-0432.CCR-21-0967","article-title":"FDA approval summary: Pralsetinib for the treatment of lung and thyroid cancers with RET gene mutations or fusions","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib207","series-title":"First in Human Phase 1 Study of AOH1996 in Patients with Refractory Solid Tumors","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e41457_bib209","series-title":"Patients with Advanced Solid Tumor Malignancies","article-title":"A phase 1, open-label, multicenter study to evaluate the safety and efficacy of the oral cyclin A\/B-RxL inhibitor CID-078","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e41457_bib215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2021.02.014","volume":"161","author":"Arend","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib216","article-title":"VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial","volume":"12","author":"Coffman-D\u2019Annibale","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib219","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S1525-0016(16)36068-3","article-title":"Phase I study of pbi-shRNATM STMN1 bilamellar invaginated vesicle (BIV) lipoplex (LP) via intratumoral injection in advanced cancer","volume":"20","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.heliyon.2024.e41457_bib222","author":"Sanofi"},{"key":"10.1016\/j.heliyon.2024.e41457_bib223","author":"Sanofi"},{"key":"10.1016\/j.heliyon.2024.e41457_bib227","article-title":"Phase I clinical trial of NEO-201, an anti-tumor-associated CEACAM-5\/6 monoclonal antibody in solid tumors","volume":"40","author":"Cole","year":"2022","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.heliyon.2024.e41457_bib228","author":"Zhang"},{"key":"10.1016\/j.heliyon.2024.e41457_bib229","series-title":"Alone and in Combination with Tislelizumab in Patients with Selected Advanced or Metastatic Solid Tumors","article-title":"Phase 1a\/1b study investigating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of BGB-B167","author":"BeiGene","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e41457_bib230","series-title":"A Phase I, Multicenter, Open-Label First in Human Study of Anti-CEACAM5 Antibody Drug Conjugate M9140 in Participants with Advanced Solid Tumors (PROCEADE-CRC-01)","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e41457_bib232","series-title":"Tolerability, Pharmacokinetics, and Antineoplastic Activity of SY-5007 in Patients with RET-Altered Advanced Solid Tumor","article-title":"Shouyao Holdings (Beijing) Co. LTD, A phase I\/II, open-label, single-arm, study to evaluate the safety","year":"2023"},{"key":"10.1016\/j.heliyon.2024.e41457_bib235","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179998","article-title":"BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity","volume":"134","author":"Westaby","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e41457_bib236","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000438902","article-title":"Reviewing the osteotropism in neuroendocrine tumors: the role of epithelial-mesenchymal transition","volume":"103","author":"Cives","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.heliyon.2024.e41457_bib237","doi-asserted-by":"crossref","unstructured":"F. de O. Serachi, S.K.N. Marie, S.M. Oba-Shinjo, Relevant coexpression of STMN1, MELK and FOXM1 in glioblastoma and review of the impact of STMN1 in cancer biology, MedicalExpress (S\u00e3o Paulo, Online) vol. 4 (n.d.) M170506. https:\/\/doi.org\/10.5935\/MedicalExpress.2017.05.06.","DOI":"10.5935\/MedicalExpress.2017.05.06"},{"key":"10.1016\/j.heliyon.2024.e41457_bib238","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.624079","article-title":"MYCN function in neuroblastoma development","volume":"10","author":"Otte","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib239","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1078-0432.CCR-17-1872","article-title":"Targeting the MYCN-PARP-DNA damage response pathway in neuroendocrine prostate cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/PAI.0000000000000647","article-title":"EZH2 expression in intestinal neuroendocrine tumors","volume":"27","author":"Faviana","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib241","article-title":"UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.heliyon.2024.e41457_bib242","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1158\/1078-0432.CCR-11-3264","article-title":"Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4\/cdk6","volume":"18","author":"Tang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e41457_bib243","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13277-014-2629-y","article-title":"Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling","volume":"36","author":"Schimmack","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib244","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/receptors3020008","article-title":"Exploring emerging therapeutic targets and opportunities in neuroendocrine tumors: updates on receptor tyrosine kinases","volume":"3","author":"Toffoli","year":"2024","journal-title":"Receptors"},{"key":"10.1016\/j.heliyon.2024.e41457_bib245","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2826.2006.01425.x","article-title":"Epidermal growth factor receptor expression and activation in neuroendocrine tumours","volume":"18","author":"Shah","year":"2006","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib246","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46927-x","article-title":"Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing","volume":"13","author":"Sztankovics","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e41457_bib247","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.562505","article-title":"mTOR pathway in gastroenteropancreatic neuroendocrine tumor (GEP-NETs)","volume":"11","author":"Zanini","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e41457_bib248","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000334891","article-title":"EGFR\/TGF\u03b1 and TGF\u03b2\/CTGF signaling in neuroendocrine neoplasia: theoretical therapeutic targets","volume":"97","author":"Kidd","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.heliyon.2024.e41457_bib249","doi-asserted-by":"crossref","first-page":"R271","DOI":"10.1530\/ERC-21-0208","article-title":"The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer","volume":"28","author":"Pittaway","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2024.e41457_bib250","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.18632\/aging.202376","article-title":"Functional characterization of DLK1\/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors","volume":"13","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e41457_bib251","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202302489RRR","article-title":"Hypoxia exosome derived CEACAM5 promotes tumor-associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9","volume":"38","author":"Ye","year":"2024","journal-title":"Faseb. J."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024174889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024174889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:25:33Z","timestamp":1776374733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024174889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":217,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405844024174889"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41457","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e41457"}}